XL147
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for XL147, covering 2012-03-23 to 2016-06-03. Get the full timeline:
Most recent: Clinical Trial Update: Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Carcinoma [Phase 2]